Preventing avoidable central line–associated bloodstream infections: Implications for probiotic administration and surveillance

Central line-associated bloodstream infections (CLABSIs) are a source of morbidity and impose an important financial burden. As a public safety net health system, we continually strive to improve the quality of our care and to minimize cost. Every health care-associated infection is scrutinized to a...

Full description

Saved in:
Bibliographic Details
Published in:American journal of infection control 2016-11, Vol.44 (11), p.1427-1428
Main Authors: Skljarevski, Sonja, MD, Barner, Amanda, PharmD, BCPS, Bruno-Murtha, Lou Ann, DO
Format: Article
Language:English
Subjects:
Aged
Bacteremia - prevention & control
Catheter-Related Infections - prevention & control
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - microbiology
Diabetes Mellitus, Type 2 - therapy
Disease prevention
Enteral Nutrition
Female
Humans
Infection Control
Infectious Disease
Lactobacillus
Morbidity
Nosocomial infections
Probiotics
Probiotics - administration & dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c476t-64b115494729642e17f8cbe50838d4146e8347475bdcdfcd207efb963bb7d2793
cites cdi_FETCH-LOGICAL-c476t-64b115494729642e17f8cbe50838d4146e8347475bdcdfcd207efb963bb7d2793
container_end_page 1428
container_issue 11
container_start_page 1427
container_title American journal of infection control
container_volume 44
creator Skljarevski, Sonja, MD
Barner, Amanda, PharmD, BCPS
Bruno-Murtha, Lou Ann, DO
description Central line-associated bloodstream infections (CLABSIs) are a source of morbidity and impose an important financial burden. As a public safety net health system, we continually strive to improve the quality of our care and to minimize cost. Every health care-associated infection is scrutinized to assess whether it could have been prevented. To our surprise, one patient recently fulfilled the National Healthcare Safety Network (NHSN) surveillance definition for a CLABSI in a situation which could have been avoided if probiotics were more carefully handled.
doi_str_mv 10.1016/j.ajic.2016.07.029
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1839453377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0196655316308240</els_id><sourcerecordid>4250035141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-64b115494729642e17f8cbe50838d4146e8347475bdcdfcd207efb963bb7d2793</originalsourceid><addsrcrecordid>eNp9kdtqFTEUhoNY7Lb6Al5IwOsZc5pkRkQoRdtCoYJ6HXJYIxlnJttk9obe6TP0DX0SM921ghde5fT_a-X_FkIvKKkpofL1UJshuJqVfU1UTVj3CG1ow1TFWScfow2hnaxk0_Bj9DTngRDScdk8QcdMtZQQqTbo58cEe5iXMH_FZh-DN3YE7MpNMiMewwy_ftyanKMLZgGP7Rijz0sCM-Ew9-CWEOf8Bl9O2zE4c3fCfUx4m6INcQkOGz-FORTP3Ss2s8d5l_YQxtHMDp6ho96MGZ7fryfoy4f3n88uqqvr88uz06vKCSWXSgpLaSM6oUo2wYCqvnUWGtLy1gsqJLRcKKEa653vnWdEQW87ya1VnqmOn6BXh7rlZ993kBc9xF2aS0tNW96JhnOlioodVC7FnBP0epvCZNKNpkSv1PWgV-p6pa6J0oV6Mb28L72zE_gHyx_MRfD2IIAScB8g6ewClPA-pIJQ-xj-X__dP3ZXJlNwj9_gBvLfHDozTfSnde7r2KnkpGWC8N-n2qv-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1839453377</pqid></control><display><type>article</type><title>Preventing avoidable central line–associated bloodstream infections: Implications for probiotic administration and surveillance</title><source>Elsevier</source><creator>Skljarevski, Sonja, MD ; Barner, Amanda, PharmD, BCPS ; Bruno-Murtha, Lou Ann, DO</creator><creatorcontrib>Skljarevski, Sonja, MD ; Barner, Amanda, PharmD, BCPS ; Bruno-Murtha, Lou Ann, DO</creatorcontrib><description>Central line-associated bloodstream infections (CLABSIs) are a source of morbidity and impose an important financial burden. As a public safety net health system, we continually strive to improve the quality of our care and to minimize cost. Every health care-associated infection is scrutinized to assess whether it could have been prevented. To our surprise, one patient recently fulfilled the National Healthcare Safety Network (NHSN) surveillance definition for a CLABSI in a situation which could have been avoided if probiotics were more carefully handled.</description><identifier>ISSN: 0196-6553</identifier><identifier>EISSN: 1527-3296</identifier><identifier>DOI: 10.1016/j.ajic.2016.07.029</identifier><identifier>PMID: 27810067</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Bacteremia - prevention &amp; control ; Catheter-Related Infections - prevention &amp; control ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - microbiology ; Diabetes Mellitus, Type 2 - therapy ; Disease prevention ; Enteral Nutrition ; Female ; Humans ; Infection Control ; Infectious Disease ; Lactobacillus ; Morbidity ; Nosocomial infections ; Probiotics ; Probiotics - administration &amp; dosage</subject><ispartof>American journal of infection control, 2016-11, Vol.44 (11), p.1427-1428</ispartof><rights>Association for Professionals in Infection Control and Epidemiology, Inc.</rights><rights>2016 Association for Professionals in Infection Control and Epidemiology, Inc.</rights><rights>Copyright Mosby-Year Book, Inc. Nov 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-64b115494729642e17f8cbe50838d4146e8347475bdcdfcd207efb963bb7d2793</citedby><cites>FETCH-LOGICAL-c476t-64b115494729642e17f8cbe50838d4146e8347475bdcdfcd207efb963bb7d2793</cites><orcidid>0000-0001-8657-7422</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27810067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Skljarevski, Sonja, MD</creatorcontrib><creatorcontrib>Barner, Amanda, PharmD, BCPS</creatorcontrib><creatorcontrib>Bruno-Murtha, Lou Ann, DO</creatorcontrib><title>Preventing avoidable central line–associated bloodstream infections: Implications for probiotic administration and surveillance</title><title>American journal of infection control</title><addtitle>Am J Infect Control</addtitle><description>Central line-associated bloodstream infections (CLABSIs) are a source of morbidity and impose an important financial burden. As a public safety net health system, we continually strive to improve the quality of our care and to minimize cost. Every health care-associated infection is scrutinized to assess whether it could have been prevented. To our surprise, one patient recently fulfilled the National Healthcare Safety Network (NHSN) surveillance definition for a CLABSI in a situation which could have been avoided if probiotics were more carefully handled.</description><subject>Aged</subject><subject>Bacteremia - prevention &amp; control</subject><subject>Catheter-Related Infections - prevention &amp; control</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - microbiology</subject><subject>Diabetes Mellitus, Type 2 - therapy</subject><subject>Disease prevention</subject><subject>Enteral Nutrition</subject><subject>Female</subject><subject>Humans</subject><subject>Infection Control</subject><subject>Infectious Disease</subject><subject>Lactobacillus</subject><subject>Morbidity</subject><subject>Nosocomial infections</subject><subject>Probiotics</subject><subject>Probiotics - administration &amp; dosage</subject><issn>0196-6553</issn><issn>1527-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kdtqFTEUhoNY7Lb6Al5IwOsZc5pkRkQoRdtCoYJ6HXJYIxlnJttk9obe6TP0DX0SM921ghde5fT_a-X_FkIvKKkpofL1UJshuJqVfU1UTVj3CG1ow1TFWScfow2hnaxk0_Bj9DTngRDScdk8QcdMtZQQqTbo58cEe5iXMH_FZh-DN3YE7MpNMiMewwy_ftyanKMLZgGP7Rijz0sCM-Ew9-CWEOf8Bl9O2zE4c3fCfUx4m6INcQkOGz-FORTP3Ss2s8d5l_YQxtHMDp6ho96MGZ7fryfoy4f3n88uqqvr88uz06vKCSWXSgpLaSM6oUo2wYCqvnUWGtLy1gsqJLRcKKEa653vnWdEQW87ya1VnqmOn6BXh7rlZ993kBc9xF2aS0tNW96JhnOlioodVC7FnBP0epvCZNKNpkSv1PWgV-p6pa6J0oV6Mb28L72zE_gHyx_MRfD2IIAScB8g6ewClPA-pIJQ-xj-X__dP3ZXJlNwj9_gBvLfHDozTfSnde7r2KnkpGWC8N-n2qv-</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Skljarevski, Sonja, MD</creator><creator>Barner, Amanda, PharmD, BCPS</creator><creator>Bruno-Murtha, Lou Ann, DO</creator><general>Elsevier Inc</general><general>Mosby-Year Book, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-8657-7422</orcidid></search><sort><creationdate>20161101</creationdate><title>Preventing avoidable central line–associated bloodstream infections: Implications for probiotic administration and surveillance</title><author>Skljarevski, Sonja, MD ; Barner, Amanda, PharmD, BCPS ; Bruno-Murtha, Lou Ann, DO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-64b115494729642e17f8cbe50838d4146e8347475bdcdfcd207efb963bb7d2793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Bacteremia - prevention &amp; control</topic><topic>Catheter-Related Infections - prevention &amp; control</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - microbiology</topic><topic>Diabetes Mellitus, Type 2 - therapy</topic><topic>Disease prevention</topic><topic>Enteral Nutrition</topic><topic>Female</topic><topic>Humans</topic><topic>Infection Control</topic><topic>Infectious Disease</topic><topic>Lactobacillus</topic><topic>Morbidity</topic><topic>Nosocomial infections</topic><topic>Probiotics</topic><topic>Probiotics - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Skljarevski, Sonja, MD</creatorcontrib><creatorcontrib>Barner, Amanda, PharmD, BCPS</creatorcontrib><creatorcontrib>Bruno-Murtha, Lou Ann, DO</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of infection control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Skljarevski, Sonja, MD</au><au>Barner, Amanda, PharmD, BCPS</au><au>Bruno-Murtha, Lou Ann, DO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preventing avoidable central line–associated bloodstream infections: Implications for probiotic administration and surveillance</atitle><jtitle>American journal of infection control</jtitle><addtitle>Am J Infect Control</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>44</volume><issue>11</issue><spage>1427</spage><epage>1428</epage><pages>1427-1428</pages><issn>0196-6553</issn><eissn>1527-3296</eissn><abstract>Central line-associated bloodstream infections (CLABSIs) are a source of morbidity and impose an important financial burden. As a public safety net health system, we continually strive to improve the quality of our care and to minimize cost. Every health care-associated infection is scrutinized to assess whether it could have been prevented. To our surprise, one patient recently fulfilled the National Healthcare Safety Network (NHSN) surveillance definition for a CLABSI in a situation which could have been avoided if probiotics were more carefully handled.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27810067</pmid><doi>10.1016/j.ajic.2016.07.029</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-8657-7422</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0196-6553
ispartof American journal of infection control, 2016-11, Vol.44 (11), p.1427-1428
issn 0196-6553
1527-3296
language eng
recordid cdi_proquest_journals_1839453377
source Elsevier
subjects Aged
Bacteremia - prevention & control
Catheter-Related Infections - prevention & control
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - microbiology
Diabetes Mellitus, Type 2 - therapy
Disease prevention
Enteral Nutrition
Female
Humans
Infection Control
Infectious Disease
Lactobacillus
Morbidity
Nosocomial infections
Probiotics
Probiotics - administration & dosage
title Preventing avoidable central line–associated bloodstream infections: Implications for probiotic administration and surveillance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T16%3A13%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preventing%20avoidable%20central%20line%E2%80%93associated%20bloodstream%20infections:%20Implications%20for%20probiotic%20administration%20and%20surveillance&rft.jtitle=American%20journal%20of%20infection%20control&rft.au=Skljarevski,%20Sonja,%20MD&rft.date=2016-11-01&rft.volume=44&rft.issue=11&rft.spage=1427&rft.epage=1428&rft.pages=1427-1428&rft.issn=0196-6553&rft.eissn=1527-3296&rft_id=info:doi/10.1016/j.ajic.2016.07.029&rft_dat=%3Cproquest_cross%3E4250035141%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c476t-64b115494729642e17f8cbe50838d4146e8347475bdcdfcd207efb963bb7d2793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1839453377&rft_id=info:pmid/27810067&rfr_iscdi=true